Heart transplant patients are followed for up to a year with periodic right heart catheterizations (RHCs) to identify post-transplant complications and guide treatment. Positive outcomes are associated with a steady reduction of right ventricular and pulmonary artery pressure posttransplant toward normal levels of right-side pressure (about 20mmHg) as measured by right heart catheterization. However, standard RHC measures have the potential to identify much more about the progression of the cardiovascular state during recovery if combined with mechanistic computational cardiovascular system models. The purpose of this study is two-fold: to understand how cardiovascular system models can be used to represent a patient's cardiovascular state and to use these models on a subset of patients where we have longitudinal RHCs over the span of the first year to track post-transplant recovery and outcome. The cardiovascular systems model used here and its underlying mechanistic parameters are evaluated using sensitivity analysis, parameter subset selection and parameter identifiability to understand what information about the cardiovascular state can be reliably extracted from RHC data. Patient-specific models are then identified for ten patients from their first post-transplant RHC. Parameters representing ventricular diastolic filling, systemic resistance, pulmonary vein elastance, pulmonary resistance, pulmonary artery elastance, pulmonary valve resistance and aortic elastance are identified for each patient using this approach. Multiple RHCs from five of these patients are analyzed longitudinally to visualize progression of recovery using simulated left and right ventricular pressure-volume loops exhibiting the potential for this method to understand post-transplant remodeling and recovery of the entire cardiovascular system.
Introduction
Better outcomes for patients with cardiovascular pathophysiologies are currently being driven by an increasing number of clinical measures (both noninvasive and invasive) to determine diagnoses and guide treatment. These measures are correlated to successful therapeutic strategies for a given condition, but the underlying physiological mechanisms involved in the success of a given treatment for a given patient are often not explicitly determined. An example is the assessment of cardiovascular function using right heart catheterization measures after heart transplant. Repeated right heart catheterization (RHC) measurements of ventricular and pulmonary arterial pressure are used to monitor post-transplant pulmonary hypertension, which if not resolved or increases in magnitude can lead to complications in post-transplant recovery [1] [2] [3] [4] .
These measurements are used to inform post-transplant treatment and intervention and have been associated with better outcome, yet they only provide a description of the upper level phenotype of the cardiovascular system and do not take advantage of the relationships that exist in the cardiovascular system between pressures, volumes and flow. It has been suggested 5, 6 , that a more complete evaluation of the cardiovascular state and detection of dysfunction in the transplanted heart could foster even better outcomes. This study builds a computational methodology for utilizing current clinical measures to provide estimates of the pressure, flow, and volume in the cardiovascular system along with mechanistic functional parameters, which can aid in prediction of heart transplant outcome and guide corrective treatment.
In addition to RHC measurements, echocardiography, magnetic resonance imaging and Doppler imaging have been used to track metrics of cardiac function post-transplantation [7] [8] [9] [10] . However, the use of these non-invasive modalities has not supplanted the standard clinical sequence of RHC measures for the evaluation of cardiovascular function post-transplant. In one study utilizing tissue Doppler the non-invasive measurements were simply used to optimally time when the RHC were to be obtained in heart transplant patients 7 . These prospective studies focus on a single measure of interest or biomarker, which is hypothesized to be able to guide therapy.
A clinical study is then designed to measure this biomarker and a correlation to outcome is hopefully made. This approach is problematic in two ways. First, this methodology is inefficient since if the prospective biomarker does not discriminate outcomes, another biomarker must be selected and the process is repeated . Secondly, this approach ignores the fact that post-transplant recovery and outcome are multifactorial in nature involving the function of the entire cardiovascular system working in conjunction with the transplanted heart.
Since information from electronic health records (EHRs) are now being deidentified and made available to researchers, large sets of data can now be assembled to perform analyses in a retrospective manner where the clinical outcome is already known. These research-ready repositories of EHR data are currently being assembled at the University of Michigan (Data Office for Clinical and Translational Research, DOCTR) and at other institutions facilitate access to clinical measures such as the RHC data from heart transplant patients used in this study.
Moving forward, combinations of clinical measures from EHRs have the potential to be used to find correlations with clinical outcome in a statistical sense. Better yet, as we are doing in this study, we combine clinical measures from EHRs with computational modeling to providing mechanistic representation of individual patient function extracting correlations of lower level functional phenotypes with patient outcome. The implementation of this mechanistic representation is through the use of mathematical models of cardiovascular physiology, which have been developed and refined over several decades [11] [12] [13] . Figure 1 illustrates our overall goals of this study where RHC data is accessed and then analyzed with computational models to provide patient specific instantiations of the model that are used to predict function that cannot be measured clinically. A key part of this study is to verify if given a limited set of data extracted from a typical heart transplant patient's EHR we can create a patient specific instantiation of a mathematical model of cardiovascular system dynamics. One important point of this exploration is to select the granularity of model which can be informed by the clinical data and then quantify the degree to which the identified parameters in the model can be uniquely specified. These patient specific instantiations of the mathematical model may be used to infer underlying differences between patients, which can be used to understand how changes in cardiovascular function are associated with outcome. By overlaying our physiological knowledge of the cardiovascular system with patient specific data we are constraining the system to represent an individual patient. Since this is a retrospective analysis this approach opens the potential to search for early indicators of positive and negative heart transplant outcomes on record in the EHRs.
In this proof of concept study, we employ a mechanistic computational model of cardiovascular physiology inspired by the model developed by Smith et al. 12 to identify model parameters informed by RHC and aortic blood pressure measurements from ten heart transplant patients.
The model used here is developed wiht available RHC data that does not contain any pressure waveforms and does not include any direct measures of left ventricular function. In this model, a detailed selection of identifiable parameters is made using sensitivity and correlation analysis of the model parameters with respect to the available data. After an identifiable subset of model parameters is selected the initial post-transplant RHC datasets from each of the ten patients records are then used to produce patient-specific models. Of the ten patients' datasets, five contain longitudinal RHC measurements at an additional 3-7 post-transplant timepoints over the span of 12 months. We then analyze these longitudinal RHC measures from these five patients to quantify how underlying cardiovascular function for each patient is changing during posttransplant recovery.
Methods

RHC measures:
The RHC data was extracted from the clinical data repository at the University of Washington Medicine Regional Heart Center. This retrospective data capture was approved by the Institutional Review Board (IRB) at the University of Washington. The data in the repository was exported from the Mac-Lab Hemodynamic Recording System (GE Healthcare, Chicago, IL, USA) used in the UW cardiac catheterization lab. The repository was queried for RHC datasets from heart transplant patients with catheterization procedures performed between March 6, 2014 to March 21, 2016. Ten patient records were retrieved and of these, five records contained multiple RHC measures from a four-to twelve-month period immediately following the transplant. The selected datasets contained twelve clinically measured values: systolic and diastolic pressure measured in the right ventricle, the main pulmonary artery, and the aorta; an average pulmonary capillary wedge pressure, heart rate, cardiac output, body weight, height, and gender, as shown in Table 1 (Table S1 of the supplementary material gives all data used in this study including longitudinal RHC data for a subset of the patients). The clinical data repository also includes estimates for systemic vascular and pulmonary vascular resistance in these patients however, these measures in the EHR are not true measures but are calculated from a subset of the twelve clinical measures listed above, and are therefore not used in this study, as these quantities can directly be extracted from model predictions.
Mathematical model:
In the style of the model by Smith et al. 12 , we developed a cardiovascular systems level model (shown in Figure 2 ) to study patient-specific cardiovascular function in heart transplant patients. To avoid overparameterization our aim was to set up the simplest model that can simulate the RHC and aortic blood pressure data. The main differences between our model and the one by Smith et al. 12 is that (1) compartments represents the resistance of the blood passing through capillaries or a heart valve and is analogous to electrical resistance. Diodes are used to simulate one-way valves preventing blood from exiting the ventricles in the wrong direction. The muscle contractions within the heart are modeled using an exponential activation function defined over one cardiac cycle as
where 2 is the heart rate and 3 is half the length of the cardiac cycle (4 = 1/2). This creates a symmetric curve about 3 bounded by 0 ≤ $(() ≤ 1 and denotes the phase of the cardiac cycle.
The end systolic pressure (" 9: ) and volume (# 9: ) in the left and right ventricles are assumed to be linearly related by the end-systolic ventricular elastance ($ 9: ) via
where # < is the end systolic volume at zero pressure. Similarly, the end diastolic pressure (" 9< ) is related nonlinearly to end diastolic volume (# 9< ) by
where " = is the pressure at the unstressed volume # = , and C is the exponential constant.
Combining Eq. (2) and (3) gives
which calculates the pressure in each ventricle where " .H is the tissue pressure in the thoracic cavity. As $(() oscillates through the cardiac cycle, Eq. (4) weighs the contributions of the systolic and diastolic pressure to give the total pressure in the ventricle. Since the pulmonary arteries and veins are located in the thoracic cavity, the pressure and volume are related as
while the majority of the systemic arteries and veins are outside the thoracic cavity, giving
Blood flow in and out of each compartment is proportional to the difference in surrounding pressure and is derived from Ohm's Law
and conservation of volume implies
for each compartment. To model the one-way heart valves, we must restrict flow when the valve should be closed, giving (Table 2) are extracted from the clinical data and literature using an approach similar to the one outlined in Marquis et al. 14 translated to analysis of human data.
Blood volume:
The total blood volume (TBV in mL) 15 and body surface area (BSA in m 2 ) 16 for females (11) Compartment models as the one presented here only track stressed volume, which for mice amount to approximately 30% of the total blood volume [17] [18] [19] . Of this stressed volume, 6.5% is housed in the left ventricle, 5.5% in the right ventricle, 3% in the pulmonary artery, 54% in the pulmonary vein, 9% in the aorta, and 22% in the vena cava 18 . The parameters used in Eqs. (2) and (3) listed in Table 2 are calculated from data and extracted from literature.
Pressure:
For compartments for which we do not have data, we relate quantities to values in the anterior or posterior compartment. We assume the pulse pressure of the pulmonary vein is 20% of the pulmonary artery, and that the systolic pulmonary vein pressure is the pulmonary capillary wedge pressure plus 50% of the pulmonary vein pulse pressure. Likewise, the diastolic pulmonary vein pressure is the wedge pressure less 50% of the pulse pressure. We assume a 2% pressure drop across the mitral, aortic, and tricuspid valves, giving us " QO,:l:. = 1.02 " PL,:l:.
" QO,<JP:. = 0.98 " iM,<JP:.
" Og,<JP:. = 1.02 `h O,<JP:. .
Furthermore, we assume that the pulse pressure in the vena cava (" Og,ii ) is 5% of aortic pulse pressure, and thus the systolic pressure in the vena cava follows " Og,:l:. = " Og,<JP:. + " Og,ii . 
where BSA denotes the body surface area calculated in Eq. (11). From Eq. (14) and (15), we can calculate the volume of the left ventricle at the end of systole by
Elastance: Nominal elastance parameter values are calculated from Eq. (2), (5), and (6) with the estimated compartmental blood volume (CBV) in compartment i as
where " .H is included for compartments housed in the thoracic cavity and # <,J is included for the left and right ventricle compartments.
Resistances: Nominal resistance parameter values are calculated from Ohm's Law using cardiac output (3ç) as our baseline flow and the corresponding pressure measurements by
For 10 unique data samples, we overwrote the systolic pulmonary artery pressure as this measurement was greater than or equal to the systolic right ventricle pressure. During systole, the pulmonary valve is open and blood flows from the right ventricle and into the pulmonary artery;
however, due to the pressure gradient measured, blood would not flow since the valve would be closed. Therefore, we set " iP,:l:. = 0.95 " hO,:l:. (21) so that blood flows appropriately in these instances. All nominal parameter values and their units are listed in Table 2 .
Sensitivity Analysis: Sensitivity analysis calculates how the model output changes in response to perturbed parameter values. We define a sensitivity matrix é as
where o(( J , e) represents the model output at the ë'th time point, and e è is the ì'th parameter, in log-transformed space. Due to the complexity of the model, é is difficult to calculate analytically, so similar to Pope et al. 21 we use finite differences to estimate é by
where ℎ is chosen to reflect the accuracy of the model, and + J is the unit vector in the ë'th direction. To ensure that the error in sensitivities is on the same scale as the solver error in the model (ñ), it should follow that ℎ = √ñ. To approximate the influence that each parameter has on the model, we rank the sensitivities, % è , as the two-norm over each column of é
Parameter Subset Selection: In addition to being sensitive, it is important that parameters estimated are not correlated 14 . So, to determine a subset of parameters we used sensitivity-based covariance analysis to get a priori insight into potential correlation structure. For all sensitive parameters, we calculate the covariance matrix
where é denotes the sensitivity matrix. This formulation is valid under the assumption that the variance is constant. The covariance matric _ is defined if é û é (also known as the Fisher information matrix) can be inverted necessitating the a priori removal of the any parameters that are perfectly correlated. Parameters for which _ Jè > ü (here we let ü = 0.9) are denoted correlated. Following the structured correlation method by Ottesen and Olufsen 22 , the covariance matrix is analyzed for all sensitive parameters. It is an iterative algorithm that removes the least sensitive parameter from a pair of correlated parameters. Parameters are removed sequentially until an uncorrelated subset is identified. Before the structured analysis discussed above, analytical knowledge is used to identify parameters that appear in structurally correlated combinations. All parameters that are removed from the subset are fixed at their nominal value.
This analysis is local in nature as the sensitivity matrix is evaluated at nominal parameter values determined for each patient.
Model Optimization and Parameter Identifiability: Next we use the cardiovascular system model to reproduce the clinical measures from the RHC procedure along with aortic blood pressure. Clinical measures of height, weight and gender are used to estimate total blood volume (Eq. 10) and heart rate is used to drive the model (Eq. 1) while the remaining measures are matched to the output of the model simulation (light gray shaded measures in Table 1 ). For each patient, we estimate a subset of parameters e * , that minimize the least squares error † =°.°, Once we have identified patient-specific models for each set of RHC and aortic blood pressure data we can further investigate identifiability and correlation around a representative set of optimized parameters from one patient for each of the two parameter subsets. To overcome the limitation of the local approach, similar to Marquis et al. 14 subsets of parameters to analyze. The first is based on known parameters of physiological interest; whereas the second is formed to include identifiable parameters determined from local sensitivity and structured correlation analysis. Figure 3 presents the normalized ranked parameter sensitivities for a characteristic data set and the two parameter subsets chosen for this study.
% PO , 3, and % m. are not included in the subset as their ranked sensitivity value is less than 0.01.
These parameters were fixed at their nominal values and not included in correlation analysis. For the remaining parameters, we used the structured correlation algorithm mentioned 22 to determine an identifiable parameter set. For all patients, we used a correlation threshold of ü = 0.9. This analysis revealed that the sensitivity-based identifiable parameter subset:
e ≤ = {C hO , C QO , % :l: , $ iM , % iMQ , $ iP , % iO , $ PL } is identifiable. Results shown in Figure 4 for patient 233, are obtained estimating the sensitivitybased identifiable subset e ≤ , while minimizing the least square error Eqn. (26) . Optimized parameter values e ≤ Li. are given in Table 3 .
Similar results are shown in Figure 5 for model optimization to data for patient 233 using the physiologically-based parameter subset e ≥ = {$ hO , $ QO , % :l: , $ iM , % iMQ , $ iP , % iO , $ PL , # <,QO } with the optimized parameter values given in Table 3 . Nominal parameter values are calculated as in Table 2 using data given in Table 1 for each patient. A table with optimized parameter values for the initial RHC dataset for each patient is given in the supplementary material ( Table   S2 ). Note that the two subsets e ≤ and e ≥ have 6 parameters in common, e gLm = {$ iM , $ iMQ, $ iP , $ PL , % :l: , % iMQ , % iO }. From a physiological point of view, the systolic elastances of the left and right ventricles ($ QO and $ hO ) are easier to interpret than the parameters defining diastolic filling (C QO and C hO ) and therefore they are included in the physiological subset e ≥ .
However, correlation analysis revealed that parameters $ hO & C hO and $ QO & C QO are correlated and that the elastance parameters are less sensitive. Therefore the identifiable parameter set e ≤ includes C QO , C hO and fixes$ QO and $ hO at their nominal values. Next, we observe # <,QO is strongly correlated with $ hO , $ QO , % :l: , $ iM , and $ PL . Removing # <,QO from the subset, fixing it at its nominal value, eliminated correlations within the remaining subset.
When we optimize e ≤ and e ≥ , the residual least squares cost is on the same order of magnitude Parameter identifiability: We performed a delayed rejection adaptive metropolis (DRAM)
analysis to confirm the degree of identifiability for each of our two parameter subsets and to further uncover which parameters in the subset are correlated. For each of the two parameter subsets e ≤ and e ≥ we set up normal joint a priori distribution with the mean obtained from the point estimates discussed above. The DRAM algorithm was run with 100,000 sample points. To ensure that our solutions converge to steady state prior to calculating posterior distributions and correlations we removed the burn-in set to 10,000 sample points. Figure 6 shows that for both parameter subsets the chains have converged (top two panels). The bottom panels in Figure 6 show the posterior distributions for each parameter in both subsets. For the physiological subset e ≥ , we observed that the parameter # <,QO for the dead space volume in the left ventricle has an identical distribution as the parameter $ QO , the elastance of the left ventricle. This suggest that the parameters are correlated with a single valued relation; this is equivalent to saying their
Pearson correlation is +1. This correlation is confirmed in Figure 7 
Discussion
In this study, we have developed an approach where cardiovascular system model parameters sensitive to the clinically measured cardiovascular variables are selected, then estimated to closely represent RHC and aortic blood pressure data, and subsequently used to predict cardiovascular function in heart transplant patients. We use this approach to make longitudinal predictions of cardiovascular function, elucidating changes over time, in an effort to provide insight into trends that translate to improved treatment after heart transplant. In the process, we
showed that selecting an identifiable parameter subset is of vital importance to confidently determine mechanistic model parameters. These patient-specific models of cardiovascular function are used to predict ventricular elastance in end systole, diastolic filling function, aortic stiffness, total peripheral resistance, and generate left and right ventricular pressure-volume loops, each of which is not directly measurable in the clinic.
Model parameter subset selection. The model selected for this study was developed to estimate the systolic and diastolic pressures, average pulmonary capillary wedge pressure and cardiac output obtained from EHR records. Using the Smith et al. 12 cardiovascular systems model as the reference model we carefully selected components that could be informed by the available data.
The major components omitted were ventricular-ventricular interaction and inertance at each of the heart valves. If more detailed pressure time courses were available, it is possible a more complex cardiovascular system model could be implemented. After determining the model structure, parameters of physiologic interest were selected for optimization to data based on knowledge of the cardiovascular system and what may be important to quantify for evaluation of cardiovascular function in post-transplanted hearts. The problem with this approach is that there is no guarantee that the RHC, aortic pressure, height, weight and gender data obtained in each patient has enough informational content to identify these parameters of physiological interest.
Therefore, we used a more objective approach, leveraging sensitivity analysis around nominal fits to the data, to select the parameters in the reduced model that can be confidently predicted with the given data.
The physiologically-based parameter subset included resistances of the systemic vasculature as having high sensitivity, however this was added to the sensitivity-based identifiable subset since we had data for right ventricular and pulmonary artery pressure across the valve along with cardiac output. This parameter should be able to be uniquely identified from the data alone however it was included as an adjustable parameter to provide maximum flexibility in matching the two pressures and cardiac output simultaneously.
A physiologically-based approach for selecting model parameters to optimize captures the intuitive reasons for parameters of interest. However, this approach does not identify correlation between parameters and therefore can produce a subset which is unidentifiable given our experimental data. In comparison, the sensitivity-based approach selected a subset with six parameters in common with the physiologically-based parameter subset objectively confirming a majority of the parameters selected physiologically while considering the ability of the data to inform the selected subset. If parameters that are non-identifiable in this current study are deemed to be important for the evaluation of heart transplant recovery the analysis methodology 
Optimized parameter relationship to CV function and subsequent model predictions.
Optimization of selected model parameters tell us about the underlying function that represents the upper level phenotype quantified clinically in this case with RHC and aortic blood pressure measures. From the optimized models of the initial datasets from the ten patients shown in Table   4 we observe that two patients (#60 and 558) have a relatively low left ventricle diastolic filling values (0.0225 and 0.0297, respectively). These two patients also have the largest predicted stroke volume (~100 mL and ~110 mL, respectively) using each of their patient-specific models.
The stroke volume is determined by the measured heart rate and cardiac output but manifests 28 . The RHC data alone shows this, however here we observe that in this patient over this time span, the ejection fraction decreases by ~60%, the left ventricular end diastolic pressure decreases from about 10 to 5 mmHg, the aortic elastance decreases (reduction in stiffness) by ~65% and the systemic resistance increases by ~10%. These characteristics describe the constellation of concurrent changes that can be quantified in not only the transplanted heart but the pulmonary and systemic cardiovascular system over time. 
Conclusion
In this study we have presented a workflow pushing model design and sensitivity analysis prior Tables   Table 1. Right heart catheter measurements extracted from the clinical data repository at the University of Washington Medicine Regional Heart Center. Figure 1 . Retrospective approach taking EHR data, applying it to a mechanistic models of the closed loop cardiovascular system to generate model versions representing cardiovascular function of each patient (or patient at different times) which can then be used to understand differences between the outcomes across populations of patients. Chronological progression earliest to latest by color is magenta, red, yellow, green, aqua, blue and black. Even in the case that an echocardiogram is performed in addition to an RHC a patient the pressure and volume are not obtained simultaneously therefore these pressure volume loops cannot be generated except by simulation as proposed here. Figure 9 . Longitudinal parameter trends for optimized parameters from the sensitivity-based identifiable parameter subset for patients 266 and 558. The RHC dataset that was selected for each patient was the first RHC dataset available post-transplant. 
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